company background image
BIOX logo

Bioceres Crop Solutions NasdaqGS:BIOX Voorraadrapport

Laatste prijs

US$6.46

Marktkapitalisatie

US$399.7m

7D

-5.6%

1Y

-46.1%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Voorraadrapport

Marktkapitalisatie: US$399.7m

Bioceres Crop Solutions Corp. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Bioceres Crop Solutions
Historische aandelenkoersen
Huidige aandelenkoersUS$6.46
52 Week HoogtepuntUS$14.05
52 Week LaagUS$5.71
Bèta0.47
11 maand verandering-12.94%
3 maanden verandering-34.88%
1 Jaar Verandering-46.08%
33 jaar verandering-56.82%
5 jaar verandering11.38%
Verandering sinds IPO31.84%

Recent nieuws en updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Recent updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Rendement voor aandeelhouders

BIOXUS ChemicalsUS Markt
7D-5.6%-1.1%-1.0%
1Y-46.1%9.8%30.3%

Rendement versus industrie: BIOX presteerde slechter dan de US Chemicals -sector, die het afgelopen jaar een rendement van 9.8 % opleverde.

Rendement versus markt: BIOX presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.

Prijsvolatiliteit

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement6.4%
Chemicals Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: BIOX heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van BIOX is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
2001n/aFederico Truccoinvestors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp. levert, samen met haar dochterondernemingen, oplossingen voor de productiviteit van gewassen. Het is actief in de segmenten Zaad en Geïntegreerde Producten, Gewasbescherming en Gewasvoeding. Het segment Zaad en Geïntegreerde Producten levert zaadeigenschappen, kiemplanten en zaadbehandelingspakketten voor gezondere gewassen met een hogere opbrengst.

Bioceres Crop Solutions Corp. Samenvatting

Hoe verhouden de winst en inkomsten van Bioceres Crop Solutions zich tot de beurswaarde?
BIOX fundamentele statistieken
MarktkapitalisatieUS$399.72m
Inkomsten(TTM)US$2.44m
Inkomsten(TTM)US$441.23m

166.2x

Koers/Winstverhouding

0.9x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
BIOX resultatenrekening (TTM)
InkomstenUS$441.23m
Kosten van inkomstenUS$265.14m
BrutowinstUS$176.09m
Overige uitgavenUS$173.65m
InkomstenUS$2.44m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.039
Brutomarge39.91%
Nettowinstmarge0.55%
Schuld/Eigen Vermogen Verhouding72.3%

Hoe presteerde BIOX op de lange termijn?

Bekijk historische prestaties en vergelijking